cholestyramine resin has been researched along with Blood Platelet Disorders in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guerci, B; Latger-Cannard, V; Lecompte, T; Sommelet, D; Tréchot, P | 1 |
| Albertini, F | 1 |
| Prof Aiuto, G | 1 |
3 other study(ies) available for cholestyramine resin and Blood Platelet Disorders
| Article | Year |
|---|---|
Platelet gigantism associated with cholestyramine therapy.
Topics: Anticholesteremic Agents; Blood Platelet Disorders; Child; Cholestyramine Resin; Gigantism; Humans; Male | 2001 |
[Tinnitus and lipid metabolism disorders. Value of early normolipemic treatment].
Topics: Anticholesteremic Agents; Blood Platelet Disorders; Cholestyramine Resin; Clofibrate; Humans; Hypercholesterolemia; Hyperlipidemias; Hypolipidemic Agents; Intracranial Arteriosclerosis; Intracranial Embolism and Thrombosis; Nicotinic Acids; Tinnitus | 1977 |
[Problems of arteriosclerosis epidemiology. Analysis of risk factors with a view to a possible therapy].
Topics: Anti-Inflammatory Agents; Anticoagulants; Antihypertensive Agents; Arteriosclerosis; Aspirin; Blood Platelet Disorders; Cholestyramine Resin; Dextrothyroxine; Diabetes Complications; Diet, Reducing; Europe; Fibrinolytic Agents; Humans; Hyperlipidemias; Hypertension; Nicotinic Acids; North America; Obesity; Phospholipids; Platelet Aggregation; Smoking | 1976 |